Request Trial
shutterstock_1755486332_anton_medvedev
Anton_Medvedev / Shutterstock.com
10 August 2021EuropeSophie Topham

UK experimental use exemptions: Part 4—the SPC manufacturing and stockpiling waiver

In the final article of a four-part series, Sophie Topham of Marks & Clerk discusses the supplementary protection certificate manufacturing waiver

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
IP finance gap risks startup exodus, EUIPO warns
13 April 2026   New report finds that just 13% of IP-owning firms have sought financing through their assets, with billions in potential funding left untapped, as structural barriers persist.
Europe
Patent office fee increases: What applicants must know
13 April 2026   Europe’s latest patent fee increases are modest at the EPO but include a rare steep hike in the UK, forcing applicants to reassess filing routes, portfolio value, and long-term cost strategies, say James Bell and Yelena Morozova.
Europe
UK patent office adopts EPO standards for AI inventions
9 April 2026   In light of Emotional Perception AI, the UKIPO has rewritten the rules for “mixed inventions". Matt Jefferies and Eric McNeil of Marks & Clerk explore what this pivot means for applicants protecting their AI technology.


Editor's picks

Closing the women's health gap offers ‘benefits for all’
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026

Editor's picks

Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026

More features

Novo Nordisk and OpenAI strike AI deal to boost drug discovery
IP finance gap risks startup exodus, EUIPO warns
Patent office fee increases: What applicants must know
UK patent office adopts EPO standards for AI inventions
Gilead to pay up to $5bn for antibody-drug conjugates push
Closing the women's health gap offers ‘benefits for all’
European patent offices raise fees
UPC refuses early knockout in Illumina–Element dispute